Premier Perspectives

The blog for insider insights in clinical development

Clinical Research: Phase 1 - Phase 4

Choose the Right FDA Program to Expedite Your Rare Oncology Trial

December 2, 2020

Featured Posts

Learn more about the latest events and updates.

Clinical Research
Phase 1 - Phase 4

Adaptive Design Methods Offer Rapid, Seamless Transition Between Study Phases in Rare Cancer Trials

November 17, 2020

Clinical Research
Phase 1 - Phase 4

Tumor-Agnostic Treatments: A Game Changer for Rare Oncology Trials

October 28, 2020